Burrill & Company is a financial services firm focused on the life sciences industry based in San Francisco. It has principal activities in private equity, venture capital, merchant banking, and media. It invests in industrial and agricultural biotechnology, pharmaceuticals, health care, and medical technology companies.
G. Steven Burrill founded Burrill & Company in 1994. Its portfolio includes MUX Greenlight Biosciences, Neurotech Pharmaceuticals, Neos Therapeutics, Cobalt Technologies, Nora Therapeutics, BetterDoctor, Catalyst Biosciences, Strand Life Sciences, Odyssey Thera, MabVax Therapeutics, CareDx, Gevo, diaDexus, Virdia, Alexza Pharmaceuticals, and Endocyte.
Funding Rounds Participated In
G. Steven Burrill
Founder and CEO